AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) announced today that its executives will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024, at 12:20 p.m. PT (3:20 p.m. ET). The presentation will be available via a live audio webcast on AbCellera's Investor Relations website, with a replay accessible afterward.

Positive

• AbCellera's participation in a prestigious event like the Goldman Sachs Global Healthcare Conference could enhance its visibility among key industry stakeholders.
• Live audio webcast availability ensures broader access to AbCellera's presentation, potentially attracting new investors.

Negative

• The press release does not provide any specific new financial or clinical data, which may disappoint investors looking for concrete updates.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240528369330/en/

Inquiries

Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005

Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When will AbCellera present at the Goldman Sachs Healthcare Conference?

AbCellera will present on June 10, 2024, at 12:20 p.m. PT (3:20 p.m. ET).

How can I access AbCellera's presentation at the Goldman Sachs Conference?

A live audio webcast of the presentation will be available on AbCellera's Investor Relations website, with a replay accessible afterward.

What is the significance of AbCellera's presentation at the Goldman Sachs Healthcare Conference?

Participation in the conference could enhance AbCellera's visibility and attract new investors.

What is AbCellera's stock symbol?

AbCellera's stock symbol is ABCL.